Jean‐Baptiste Davion

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Asymptomatic optic nerve lesions

Jean‐Baptiste Davion, Renaud Lopes, Élodie Drumez et al. · Neurology · 2020 · 56 citations

A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy

Rémi Barrois, Christine Barnérias, E. Deladrière et al. · Neuromuscular Disorders · 2023 · 20 citations · Full text

Muscle Function, Kinesiology, Sma Therapy +10

Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis

Agathe Molimard, Cyril Gitiaux, Christine Barnérias et al. · Neurology · 2022 · 18 citations

Allergy Medicine, Immunodeficiencies, Dermatology +16

Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (<scp>CANVAS)</scp>

Kathy Dujardin, Céline Tard, Emily Diglé et al. · Movement Disorders · 2024 · 16 citations · Full text